Sanofi gets drug regulator nod to market RSV therapy in India

French drugmaker Sanofi announced on Thursday that it has received approval from India's Central Drugs Standard Control Organization (CDSCO) to market its novel therapy, Beyfortus, in India. The therapy is aimed at protecting newborns and infants from respiratory syncytial virus (RSV).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l0YUjf7
via IFTTT